Broadridge Shorts Stay Quiet as Analysts Lift Targets After Results

Broadridge Financial Solutions reported first-quarter results on November 4 with short sellers largely unmoved, leaving the positioning story firmly in the background and analyst reactions at the front.

Short interest edged up just 0.2% on November 3 to around 3.06 million shares, keeping it at 2.6% of the free float. That is a low level by any standard. Borrow availability is effectively unconstrained: more than 111 million shares are available to lend against roughly 3 million already borrowed. Borrowing costs ticked down to 0.50% on November 3 from 0.64% the day before, and despite a 22% rise over the past month, the absolute level remains too modest to impede any new position. The options market told a slightly different story leading into the print. The put/call ratio settled at 0.46, about one standard deviation above its 20-day average of 0.38. That gap has narrowed from the 1.7 standard deviations flagged in the week prior to results, as the ratio eased back from the 0.50 area. Hedging demand built, then faded, without ever reaching a level that would suggest serious fear.

The more interesting development is what happened on the analyst desks after results landed. JP Morgan raised its price target to $201 from $191 while holding a Neutral rating. Morgan Stanley moved to $181 from $176, also keeping an Equal-Weight stance. Both firms lifted targets on the same day results were released, a signal of reassurance rather than conviction. The broader analyst picture is constructive: DA Davidson maintains a Buy with a $214 target, and RBC Capital has an Outperform with a $226 target. The stock closed at $183.76, so the bulls on the Street are still pointing to meaningful room above current prices, while the neutral camp sits close to where the shares are trading now.

Valuation has re-rated meaningfully over the past month. The price-to-earnings multiple has expanded by roughly 2.1 points over 30 days to 16.1 times. Price-to-book is up 0.8 points over the same period to 6.3 times. That re-rating has come alongside a 17% price rise over the past month, with the stock gaining 3.8% over the past week. Among closest peers, EFX added 6.8% on the week, TRU gained 4.2%, and ADP rose about 1%. TRI was the notable laggard, falling 5.2% over the same stretch. Broadridge's week sits comfortably within the stronger half of its peer group.

Retail attention has also picked up. Wikipedia page views and ORTEX stock page traffic are running nearly two standard deviations above Broadridge's own 90-day average, based on a Wikimedia Foundation reading as of October 22. That is an attention signal, not a revenue indicator, but it reflects the degree to which the name has re-entered investor conversations after months of relative quiet.

The factor picture is mixed. The dividend score ranks in the 99th percentile, consistent with Broadridge's long record as a reliable income payer. EPS momentum over both 30-day and 90-day windows sits in the low 40s percentile, reflecting the more cautious forward-estimate drift seen across the analyst community. The short score has been stable in the low 33s all week, with almost no movement. Buyback activity from EDGAR data for the second quarter showed shares repurchased up 240% year on year, with buyback spend up 92% to $250.8 million. That is a capital allocation fact for the period ending April 2026, not a projection, but it describes a company deploying cash at a materially faster pace than a year earlier.

What to watch next is the November 10 earnings event flagged in the data, which will give investors the first read on whether the recurring revenue growth and closed-sales momentum cited by the bulls holds through the current quarter.